These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30662430)

  • 21. Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide.
    Kuhre RE; Wewer Albrechtsen NJ; Hartmann B; Deacon CF; Holst JJ
    J Diabetes Complications; 2015 Apr; 29(3):445-50. PubMed ID: 25623632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.
    Hansotia T; Drucker DJ
    Regul Pept; 2005 Jun; 128(2):125-34. PubMed ID: 15780432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of Gastrointestinal Hormones.
    Albrechtsen NJW
    Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides.
    Falkén Y; Hellström PM; Holst JJ; Näslund E
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2227-35. PubMed ID: 21543426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of the repair of staple line dehiscence in post-RYGB patients on glucose homeostasis and gut hormones--a preliminary study.
    Durczynski A; Szymanski D; Nowicki M; Hogendorf P; Wojciechowska-Durczyńska K; Czupryniak L; Strzelczyk J
    Endokrynol Pol; 2013; 64(1):7-12. PubMed ID: 23450441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis.
    Dong CX; Brubaker PL
    Nat Rev Gastroenterol Hepatol; 2012 Dec; 9(12):705-15. PubMed ID: 23026903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut peptides and the regulation of appetite.
    Huda MS; Wilding JP; Pinkney JH
    Obes Rev; 2006 May; 7(2):163-82. PubMed ID: 16629873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones.
    Meek CL; Lewis HB; Reimann F; Gribble FM; Park AJ
    Peptides; 2016 Mar; 77():28-37. PubMed ID: 26344355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incretins, amylin and other gut-brain axis hormones in children with coeliac disease.
    Papastamataki M; Papassotiriou I; Bartzeliotou A; Vazeou A; Roma E; Chrousos GP; Kanaka-Gantenbein C
    Eur J Clin Invest; 2014 Jan; 44(1):74-82. PubMed ID: 24151959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incretin system and its role in type 2 diabetes mellitus.
    Holst JJ; Vilsbøll T; Deacon CF
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):127-36. PubMed ID: 18786605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut peptides in the regulation of food intake and energy homeostasis.
    Murphy KG; Dhillo WS; Bloom SR
    Endocr Rev; 2006 Dec; 27(7):719-27. PubMed ID: 17077190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the role of the gut in diabetic hyperglucagonaemia.
    Lund A
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incretins.
    Wu T; Rayner CK; Horowitz M
    Handb Exp Pharmacol; 2016; 233():137-71. PubMed ID: 25903418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enteroendocrine hormone mimetics for the treatment of obesity and diabetes.
    Irwin N; Flatt PR
    Curr Opin Pharmacol; 2013 Dec; 13(6):989-95. PubMed ID: 24064397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of sleeve gastrectomy and ileal transposition, alone and in combination, on food intake, body weight, gut hormones, and glucose metabolism in rats.
    Nausheen S; Shah IH; Pezeshki A; Sigalet DL; Chelikani PK
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E507-18. PubMed ID: 23800881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.
    Aaboe K; Knop FK; Vilsbøll T; Deacon CF; Holst JJ; Madsbad S; Krarup T
    Diabetes Obes Metab; 2010 Apr; 12(4):323-33. PubMed ID: 20380653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression.
    Riediger T; Bothe C; Becskei C; Lutz TA
    Neuroendocrinology; 2004; 79(6):317-26. PubMed ID: 15256809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiology, pathophysiology and therapeutic implications of enteroendocrine control of food intake.
    Elliott JA; Reynolds JV; le Roux CW; Docherty NG
    Expert Rev Endocrinol Metab; 2016 Nov; 11(6):475-499. PubMed ID: 30058920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterisation and antidiabetic utility of a novel hybrid peptide, exendin-4/gastrin/xenin-8-Gln.
    Hasib A; Ng MT; Khan D; Gault VA; Flatt PR; Irwin N
    Eur J Pharmacol; 2018 Sep; 834():126-135. PubMed ID: 30025814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.